bupropion hydrochloride
Generic: bupropion hydrochloride
Labeler: avpakDrug Facts
Product Profile
Brand Name
bupropion hydrochloride
Generic Name
bupropion hydrochloride
Labeler
avpak
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
bupropion hydrochloride 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
50268-134
Product ID
50268-134_2f9c516e-9c18-af30-e063-6394a90a4a70
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090693
Listing Expiration
2026-12-31
Marketing Start
2025-03-05
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
50268134
Hyphenated Format
50268-134
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA090693 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 30 BLISTER PACK in 1 BOX (50268-134-13) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-134-11)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2f9c516e-9c18-af30-e063-6394a90a4a70", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["2f9c5162-a6c5-e362-e063-6294a90a198d"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX (50268-134-13) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-134-11)", "package_ndc": "50268-134-13", "marketing_start_date": "20250305"}], "brand_name": "Bupropion Hydrochloride", "product_id": "50268-134_2f9c516e-9c18-af30-e063-6394a90a4a70", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "50268-134", "generic_name": "Bupropion Hydrochloride", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20250305", "listing_expiration_date": "20261231"}